Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

If there is 3+ reactions in all screening cells and all three potential donors are incompatible. What is a cause and solution?

When a transfusion antibody screen shows strong reactivity in all screening cells and none of the available donor units are compatible, the most likely issue is antibodies directed against a high-incidence red cell antigen (or multiple antibodies). These antibodies react with most donor cells because the targeted antigen is present in nearly everyone, so compatible units are scarce. The correct next step is to escalate testing to identify the exact antibody(s) and to locate antigen-negative donor units. A reference transfusion laboratory can perform an expanded antibody identification panel, determine the specificity, and guide the search for rare, antigen-negative units. In some cases, testing related donors (for example ABO-compatible siblings) may help if a family member lacks the implicated high-incidence antigen. This approach directly addresses the cause and provides a path to obtaining compatible blood.

When a transfusion antibody screen shows strong reactivity in all screening cells and none of the available donor units are compatible, the most likely issue is antibodies directed against a high-incidence red cell antigen (or multiple antibodies). These antibodies react with most donor cells because the targeted antigen is present in nearly everyone, so compatible units are scarce. The correct next step is to escalate testing to identify the exact antibody(s) and to locate antigen-negative donor units. A reference transfusion laboratory can perform an expanded antibody identification panel, determine the specificity, and guide the search for rare, antigen-negative units. In some cases, testing related donors (for example ABO-compatible siblings) may help if a family member lacks the implicated high-incidence antigen. This approach directly addresses the cause and provides a path to obtaining compatible blood.